Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones

Tuesday, May 17, 2011 General News
Email Print This Page Comment

Cardium Therapeutics, Inc.

Reconciliation of Non-GAAP Measure

As of March 31, 2011

Three Months Ended March 31,

2011

2010

Net Loss

$  (1,688,640)

$  (1,039,816)

    Add (subtract)

Stock-based compensation expense

22,519

120,479

Change in fair value of derivative liabilities

(88,170)

(437,370)

Non-GAAP net loss

$     (1,754,291)

$     (1,356,707)



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook